RankingsPricing
  1. US-listed companies
  2. INSMED Inc
  3. Financials
  4. Cash from financing

INSMED IncINSM

Market cap
$41.6B
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Dec 31, 20241,341+696.15%
Dec 31, 2023168-78.77%
Dec 31, 2022793+29.50%
Dec 31, 2021613+126.03%
Dec 31, 2020271-5.00%
Dec 31, 2019285-26.24%
Dec 31, 2018387+1.48%
Dec 31, 2017381+1142.42%
Dec 31, 201631-86.54%
Dec 31, 2015228+97.94%
Dec 31, 2014115+68.14%
Dec 31, 201368+50.68%
Dec 31, 201245-90948.00%
Dec 31, 2011-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)